Shinpoong Pharmaceutical Co Ltd historical data
| Date | Open | High | Low | Close | Adj. close | Volume |
|---|---|---|---|---|---|---|
| 2021-11-17 | 58,700.00 | 59,600.00 | 56,800.00 | 57,500.00 | 57,333.02 | 18,448 |
| 2021-11-16 | 61,100.00 | 61,400.00 | 59,400.00 | 59,600.00 | 59,426.92 | 19,040 |
| 2021-11-15 | 60,300.00 | 63,400.00 | 59,200.00 | 61,400.00 | 61,221.69 | 35,266 |
| 2021-11-12 | 53,400.00 | 70,800.00 | 53,400.00 | 60,500.00 | 60,324.31 | 168,325 |
| 2021-11-11 | 59,300.00 | 59,300.00 | 54,000.00 | 54,500.00 | 54,341.73 | 16,743 |
| 2021-11-10 | 56,200.00 | 60,000.00 | 56,200.00 | 57,900.00 | 57,731.86 | 21,294 |
| 2021-11-09 | 58,700.00 | 61,200.00 | 57,900.00 | 58,900.00 | 58,728.95 | 12,920 |
| 2021-11-08 | 63,400.00 | 63,400.00 | 57,400.00 | 59,800.00 | 59,626.34 | 31,969 |
| 2021-11-05 | 66,100.00 | 67,000.00 | 65,000.00 | 65,400.00 | 65,210.08 | 10,913 |
| 2021-11-04 | 67,500.00 | 74,200.00 | 66,800.00 | 67,100.00 | 66,905.14 | 54,496 |
| 2021-11-03 | 67,400.00 | 68,000.00 | 65,000.00 | 66,800.00 | 66,606.01 | 13,487 |
| 2021-11-02 | 64,400.00 | 68,800.00 | 64,400.00 | 67,100.00 | 66,905.14 | 20,471 |
| 2021-11-01 | 65,600.00 | 68,900.00 | 64,100.00 | 65,100.00 | 64,910.95 | 28,692 |
| 2021-10-29 | 74,400.00 | 75,000.00 | 64,200.00 | 68,000.00 | 67,802.53 | 60,159 |
| 2021-10-28 | 76,700.00 | 76,700.00 | 74,500.00 | 74,500.00 | 74,283.65 | 10,072 |
| 2021-10-27 | 78,000.00 | 78,100.00 | 76,000.00 | 76,100.00 | 75,879.00 | 10,784 |
| 2021-10-26 | 77,200.00 | 78,300.00 | 77,000.00 | 77,500.00 | 77,274.94 | 7,226 |
| 2021-10-25 | 78,000.00 | 78,300.00 | 76,000.00 | 76,800.00 | 76,576.97 | 7,343 |
| 2021-10-22 | 78,000.00 | 78,900.00 | 76,900.00 | 77,200.00 | 76,975.81 | 9,994 |
← NewerPage 21 of 21 · 1,219 trading days
Stock splits
No stock splits on record.
Dividends
| Ex-date | Amount |
|---|---|
| 2021-12-29 | 115.0000 KRW |
| 2020-12-29 | 115.0000 KRW |
Open, high, low and close are as traded (KRW). Adjusted close accounts for splits and dividends. Educational only, not financial advice.